A Risk Evaluation for Fugitive Aerosol Emissions When Using Different Nebulizer Systems; Potential Mechanisms, Impact of Device Type, and Mitigation Strategies
J. Suggett1, M. Nagel1, J. Schloss2, D. P. Coppolo3
1Trudell Medical International, London, Ontario, Canada 2Monaghan Medical Corporation, Syracuse, NY, United States, 3Monaghan Medical, Syracuse, NY, United States
Rationale
The SARS CoV2 environment has brought about a heightened awareness of the potential risks of fugitive emissions associated with nebulized aerosol drug delivery. Hence it would be useful to evaluate such risks in a methodical way.
Methods
The assessment evaluated:
- The potential mechanisms (routes) whereby nebulizers might emit aerosol or liquid medication into the local environment
- How such mechanisms may differ depending on the type of nebulizer device; and
- What mitigation strategies exist to reduce risk.


